[
  {
    "name": "Metformin",
    "drug_class": "Biguanide",
    "mechanism": "Reduces hepatic glucose production, increases insulin sensitivity",
    "half_life_hours": 6.2,
    "absorption_rate": 0.55,
    "bioavailability": 0.5,
    "primary_targets": [
      "AMPK",
      "Mitochondrial complex I"
    ],
    "side_effects": [
      "Gastrointestinal discomfort",
      "Lactic acidosis (rare)"
    ],
    "contraindications": [
      "Renal dysfunction",
      "Hepatic disease"
    ],
    "typical_dosage": "500-2000 mg daily",
    "active_compounds": [
      "Metformin hydrochloride"
    ],
    "approved_indications": [
      "Type 2 diabetes",
      "Insulin resistance",
      "PCOS"
    ]
  },
  {
    "name": "Sitagliptin",
    "drug_class": "DPP-4 inhibitor",
    "mechanism": "Inhibits dipeptidyl peptidase-4, increasing incretin levels",
    "half_life_hours": 12.4,
    "absorption_rate": 0.87,
    "bioavailability": 0.87,
    "primary_targets": [
      "DPP-4 enzyme"
    ],
    "side_effects": [
      "Upper respiratory infection",
      "Headache"
    ],
    "contraindications": [
      "History of pancreatitis"
    ],
    "typical_dosage": "100 mg daily",
    "active_compounds": [
      "Sitagliptin phosphate"
    ],
    "approved_indications": [
      "Type 2 diabetes"
    ]
  }
]